jaiagreen t1_j3ibake wrote
Reply to comment by matt7810 in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
Yes, it would, and there already are some, but at this point there are so many negative results that this seems like a waste of resources. A randomly chosen drug would be more promising -- at least it wouldn't have a bunch of evidence against it.
Viewing a single comment thread. View all comments